Recursion Pharmaceuticals, Inc. (RXRX)
$3.84-4.24%Close
BUYCRISIS · day 2
Key stats
Short interest · FINRA settlement 2026-09-30
52-week IV5.1%–490.7%
- Market cap
- $2.0B
- Beta
- 1.03
- P/E (TTM)
- -3.69
- IV-%ile
- 67
- IV ATM
- 92.7%
- Short % float
- 38.64%
- Days to cover
- 6.1
- SI change
- -11.6%
- 1W
- -17.06%
- 1M
- +12.61%
- vs SPY 1W
- -16.92%
- vs SPY 1M
- +10.10%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
ANALYST & RATINGS
LOADING…Loading analyst data…
Company news
FAQ
- What is LOPJLB’s current signal on RXRX?
- LOPJLB’s latest quantitative signal on Recursion Pharmaceuticals, Inc. (RXRX) is BUY in a CRISIS regime. Signals are updated daily.
- What market regime is RXRX in?
- Recursion Pharmaceuticals, Inc. (RXRX) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Recursion Pharmaceuticals, Inc. (RXRX) do?
- Recursion Pharmaceuticals, Inc. operates as a biotechnology firm currently in its clinical development phase. The company's mission is to revolutionize drug discovery by decoding biological processes, utilizing an integrated approach that combines technological innovations across biology, chemistry, automation, data science, and engineering. Their developmental pipeline features several clinica…